RACHEL SMITH: Open Payments
NPI 1407208283 · CLEVELAND, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 31 payments from 16 companies in 2025. Trend: 2023 $750 · 2024 $515 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $75 |
| Amgen Inc. | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| PFIZER INC. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Indivior Inc. | 3 | $43 |
| Lilly USA, LLC | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
Products named: ELIQUIS, OTEZLA, CAPLYTA, SUBLOCADE, VRAYLAR, INGREZZA, INSPIRE, BREZTRI.
Industry payments across GA — which companies pay providers there.
